LINTHICUM, Md.,
This new center has 24 treatment stations and is currently caring for approximately 145 dialysis patients. The company is considering adding six more stations to the facility, which will accommodate up to an additional 36 patients.
President & CEO
Dialysis Corporation of America owns and operates freestanding kidney
hemodialysis centers located in
This release contains forward-looking statements that are subject to risks
and uncertainties that could affect the business and prospects of the company
and cause actual results and plans to differ materially from those
anticipated. Those factors include, but are not limited to, increases in
interest rates, the possible need for and availability of additional
financing, the company's satisfying the covenants and conditions of its credit
facility, certain delays beyond the company's control with respect to future
business events, the highly competitive environment in the establishment and
operation of dialysis centers, the ability to develop or acquire additional
dialysis facilities, whether patient bases of the company's dialysis
facilities can mature to provide profitability, the extensive regulation of
dialysis operations, government rate determination for Medicare reimbursement,
pricing pressure from private payors, and other risks detailed in the
company's filings with the SEC, particularly as described in the company's
annual report on Form 10-K for the fiscal year ended
Other Dialysis Corporation of America press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the Securities and Exchange Commission are available on Dialysis Corporation of America's internet home page: http://www.dialysiscorporation.com.
CONTACT: For additional information, you may contact Dialysis Corporation of America, 1302 Concourse Drive, Suite 204, Linthicum, MD 21090; Telephone Number (410) 694-0500; Attention: Investor Relations.
SOURCE Dialysis Corporation of America